Blum, K.; Brodie, M.S.; Pandey, S.C.; Cadet, J.L.; Gupta, A.; Elman, I.; Thanos, P.K.; Gondre-Lewis, M.C.; Baron, D.; Kazmi, S.;
et al. Researching Mitigation of Alcohol Binge Drinking in Polydrug Abuse: KCNK13 and RASGRF2 Gene(s) Risk Polymorphisms Coupled with Genetic Addiction Risk Severity (GARS) Guiding Precision Pro-Dopamine Regulation. J. Pers. Med. 2022, 12, 1009.
https://doi.org/10.3390/jpm12061009
AMA Style
Blum K, Brodie MS, Pandey SC, Cadet JL, Gupta A, Elman I, Thanos PK, Gondre-Lewis MC, Baron D, Kazmi S,
et al. Researching Mitigation of Alcohol Binge Drinking in Polydrug Abuse: KCNK13 and RASGRF2 Gene(s) Risk Polymorphisms Coupled with Genetic Addiction Risk Severity (GARS) Guiding Precision Pro-Dopamine Regulation. Journal of Personalized Medicine. 2022; 12(6):1009.
https://doi.org/10.3390/jpm12061009
Chicago/Turabian Style
Blum, Kenneth, Mark S. Brodie, Subhash C. Pandey, Jean Lud Cadet, Ashim Gupta, Igor Elman, Panayotis K. Thanos, Marjorie C. Gondre-Lewis, David Baron, Shan Kazmi,
and et al. 2022. "Researching Mitigation of Alcohol Binge Drinking in Polydrug Abuse: KCNK13 and RASGRF2 Gene(s) Risk Polymorphisms Coupled with Genetic Addiction Risk Severity (GARS) Guiding Precision Pro-Dopamine Regulation" Journal of Personalized Medicine 12, no. 6: 1009.
https://doi.org/10.3390/jpm12061009
APA Style
Blum, K., Brodie, M. S., Pandey, S. C., Cadet, J. L., Gupta, A., Elman, I., Thanos, P. K., Gondre-Lewis, M. C., Baron, D., Kazmi, S., Bowirrat, A., Febo, M., Badgaiyan, R. D., Braverman, E. R., Dennen, C. A., & Gold, M. S.
(2022). Researching Mitigation of Alcohol Binge Drinking in Polydrug Abuse: KCNK13 and RASGRF2 Gene(s) Risk Polymorphisms Coupled with Genetic Addiction Risk Severity (GARS) Guiding Precision Pro-Dopamine Regulation. Journal of Personalized Medicine, 12(6), 1009.
https://doi.org/10.3390/jpm12061009
